MoneyWorks4Me

Eris Lifesciences informs about analyst meet

26 Nov 2021 Evaluate

In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting. The schedule is indicative and is subject to changes necessitated by any unforeseen developments. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1768.65
Dr. Reddys Labs. 1233.00
Cipla 1318.50
Lupin 1949.80
Zydus Lifesciences 1131.50
View more..